Europe Breast Cancer Screening Tests Industry Overview
The Europe breast cancer screening test market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. With the increasing awareness among the population and rising advances in screening test, a few other smaller players are expected to enter the market and may come to hold a substantial share. Some of the major players in the market are Allengers, Myriad Genetics, Hologic Inc., and Siemens Healthineers, among others.
Europe Breast Cancer Screening Tests Market Leaders
-
Allengers
-
Myriad Genetics, Inc.
-
Siemens Healthineers
-
Hologic Inc.
-
GE Healthcare
- *Disclaimer: Major Players sorted in no particular order